Mantle cell lymphoma (MCL) is an uncommon but aggressive form of B cell non-Hodgkin lymphoma. It often presents at an advanced stage and with a median…

Non-Hodgkin lymphoma (NHL) is the eighth most common malignancy worldwide. Diffuse large B cell lymphoma (DLBCL) is the most frequent subtype, accounting…

Inherited thrombocytopenias comprise a heterogeneous group of blood disorders with abnormalities in genes related to glycoproteins and adhesion molecules…

This presentation described the occurrence of late side effects (commonly described as ‘late effects’) in childhood cancer survivors (CCS), and how…

Chronic lymphocytic leukaemia (CLL) mainly affects elderly patients.1 With the increasing comorbidity burden and frailty in elderly patients, evaluation…

The next-generation sequencing era has repeatedly demonstrated that the amount of acquired somatic mutations in paediatric cancers can rarely account for…

Less than 50% of patients with adult acute lymphoblastic leukaemia (ALL) experience long-term survival and for those adults >60 years old, long-term…

Sickle cell disease (SCD) is the most common haemoglobinopathy worldwide and its frequency has steadily increased in Europe in the past decades. SCD is a…

“Paul, that sugar you are adding to your tea is too much,” said my mother as I added the fourth cube to my teacup. She would say the same thing when…

United Kingdom, July 26, 2016: Welcome to this year’s edition of EMJ Rheumatology, packed full of exciting news and developments from throughout the past…